| The use of thrombolytic therapy in patients presenting to a peripheral metropolitan emergency department with acute myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 8873938 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: While use of thrombolytic therapy in the management of acute myocardial infarction has become accepted practice in major teaching hospitals, its use in peripheral metropolitan hospitals has not been well accepted. AIM: To evaluate the use of thrombolytic therapy in the management of acute myocardial infarction in the Emergency Department (ED) of a peripheral metropolitan hospital. METHODS: A mixed prospective and retrospective observational study of 69 patients with acute myocardial infarction, who received thrombolytic therapy during a three year period, was conducted in a community based ED. RESULTS: Demographic data, door to drug interval, complications occurring during administration of thrombolytics and subsequent interhospital transfer were recorded. The mean door to drug interval in 1992 was 79.7 minutes (95% CI: 50.7 to 109.1) and by 1994 this had fallen to 25.6 minutes (95% CI: 18.9 to 32.3). Hypertension (22%) was the most common complication of therapy observed and cardiac arrest occurred in two cases (3.2%). A single episode of hypotension and vomiting were the only complications that occurred during interhospital transfer. There were no deaths during therapy or transfer. CONCLUSION: Thrombolytic therapy can be undertaken in the EDs of peripheral metropolitan hospitals in a safe and timely manner. There is little justification for routine medical escorts in the clinically stable post thrombolysis patient. |
| | |
Authors:
|
I G Jacobs; D M Fatovich |
Related Documents
:
|
19605778 - The tissue-type plasminogen activator story. 1904028 - Value of electrocardiographic scoring systems for the assessment of thrombolytic therap... 2448888 - Depression of tissue plasminogen activator (t-pa) activity and rise of t-pa inhibition ... 9254938 - Expanding use of thrombolytic therapy in the treatment of acute myocardial infarction i... 14708808 - Acute myocardial infarction: disposition to the operating room? 10510018 - Cardiac transplantation in a patient with protein s deficiency. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Australian and New Zealand journal of medicine Volume: 26 ISSN: 0004-8291 ISO Abbreviation: Aust N Z J Med Publication Date: 1996 Aug |
Date Detail:
|
Created Date: 1997-01-23 Completed Date: 1997-01-23 Revised Date: 2004-11-17 |
Medline Journal Info:
|
Nlm Unique ID: 1264322 Medline TA: Aust N Z J Med Country: AUSTRALIA |
Other Details:
|
Languages: eng Pagination: 539-42 Citation Subset: IM |
Affiliation:
|
School of Public Health, Curtin University of Technology, Perth, Western Australia. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Aged, 80 and over Drug Utilization Review* Emergency Service, Hospital / statistics & numerical data* Female Fibrinolytic Agents / therapeutic use Hospitals, Urban Humans Male Medical Audit Middle Aged Myocardial Infarction / drug therapy* Organizational Policy Patient Transfer Retrospective Studies Streptokinase / therapeutic use Thrombolytic Therapy / adverse effects, utilization* Time Factors Tissue Plasminogen Activator / therapeutic use Western Australia |
| Chemical | |
Reg. No./Substance:
|
0/Fibrinolytic Agents; EC 3.4.-/Streptokinase; EC 3.4.21.68/Tissue Plasminogen Activator |
| Comments/Corrections | |
Comment In:
|
Aust N Z J Med. 1997 Apr;27(2):192
[PMID:
9145190
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Primary hyperaldosteronism: a missed diagnosis in 'essential hypertensives'?
Next Document: Racial differences in incidence, outcome, and quality of life for African-Americans on hemodialysis.